Steady state study for Carbamazepine [Study Per­for­mance]

posted by labanya – 2009-02-27 14:28 (5919 d 14:44 ago) – Posting: # 3296
Views: 6,215

Hi,

We are planning to conduct a steady state BE study for carbamazepine extended release tablet of the highest dose. I would like to know:
First will the metabolite be analysed in this case?
Second if any tablet gets missed or the subject vomits after dosing then will the subject be withdrwan from the study?

Thanks

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
85 visitors (0 registered, 85 guests [including 9 identified bots]).
Forum time: 06:12 CEST (Europe/Vienna)

Only dead fish go with the current.    Scuba divers' proverb

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5